Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate whether the risk of serious infections in rheumatoid arthritis patients with tocilizumab is higher than in those with tumor necrosis factor inhibitors using th...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Sungkyunkwan University
Collaborators
NCT07209917 · Cervical Cancer, Human Papillomavirus (HPV) Infection, and more
NCT07655050 · Kidney Calculi, Urolithiasis, and more
NCT07666464 · Therapy, Pleural Infections
NCT05189925 · Chronic Granulomatous Disease, Infection
NCT05762991 · Helicobacter Pylori Infection, Premalignant Lesion
Sungkyunkwan University
Suwon, Gyeonggi-do
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions